A. Torres-Cornejo

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.

J. Macías, J. Pineda, A. Rivero, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.

J. Macías, J. Pineda, A. Rivero, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HAVCR1 Gene Haplotypes and Infection by Different Viral Hepatitis C Virus Genotypes

M. Romero-Gómez, M. González-Escribano, L. López-Cortés, 2011, Clinical and Vaccine Immunology.

Telaprevir and Ribavirin Interaction: Higher Ribavirin Levels Are Not Only Due to Renal Dysfunction during Triple Therapy

P. Viciana, L. López-Cortés, N. Espinosa, 2015, Antimicrobial Agents and Chemotherapy.

Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines

G. Lauer, A. Torres-Cornejo, 2017, Pathogens & immunity.

Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia

J. Macías, J. Pineda, A. Rivero, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

OriginalHIV-1 p24 and CD4+ T cell count during boosted protease-inhibitor monotherapy in HIV-infected patientsP24 y recuentos de CD4 durante el tratamiento con inhibidores de la proteasa potenciados en monoterapia

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2017 .

HIV-1 p24 and CD4+ T cell count during boosted protease-inhibitor monotherapy in HIV-infected patients.

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2017, Enfermedades infecciosas y microbiologia clinica.

Differentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory

Todd M. Allen, N. Hacohen, T. Eisenhaure, 2021, Nature Immunology.

Differentiation of exhausted CD8 T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory

Todd M. Allen, N. Hacohen, T. Eisenhaure, 2021, Nature Immunology.

Differential Effects of Viremia and Microbial Translocation on Immune Activation in HIV-Infected Patients Throughout Ritonavir-Boosted Darunavir Monotherapy

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2015, Medicine.

Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapy

Reyes Martín-Peña, P. Viciana, L. López-Cortés, 2014, AIDS.

Immune activation throughout a boosted darunavir monotherapy simplification strategy.

P. Viciana, A. Torres-Cornejo, R. Ruiz-Valderas, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients

J. Torre-Cisneros, J. Pineda, Á. Camacho, 2012, PloS one.

Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2016, AIDS research and human retroviruses.

Lopinavir Plasma Concentrations and Virological Outcome with Lopinavir-Ritonavir Monotherapy in HIV-1-Infected Patients

P. Viciana, L. López-Cortés, E. Sánchez-Rivas, 2013, Antimicrobial Agents and Chemotherapy.

Evolution of the innate and adaptive immune response in women with acute Zika virus infection

A. Sette, G. Lauer, D. Barouch, 2019, Nature Microbiology.

Impact of the peginterferon‐α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV‐co‐infected patients with the unfavourable non‐CC IL28B genotypes

P. Viciana, L. Jiménez-Jiménez, A. Torres-Cornejo, 2014, Journal of viral hepatitis.

Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patients.

Reyes Martín-Peña, L. López-Cortés, A. Torres-Cornejo, 2012, The Journal of antimicrobial chemotherapy.

Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia

J. Macías, J. Pineda, A. Rivero, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients

J. Torre-Cisneros, A. Gordon, J. Pineda, 2014, PloS one.

Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell‐associated viruses at viral replication episodes during darunavir/ritonavir monotherapy

P. Viciana, A. Torres-Cornejo, R. Ruiz-Valderas, 2015, HIV medicine.

Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell‐associated viruses at viral replication episodes during darunavir/ritonavir monotherapy

L. López-Cortés, A. Torres-Cornejo, R. Ruiz-Valderas, 2015, HIV Medicine.

Immune activation throughout a boosted darunavir monotherapy simplification strategy.

L. López-Cortés, A. Torres-Cornejo, R. Ruiz-Valderas, 2014, Clinical Microbiology and Infection.

Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.

J. Macías, J. Pineda, Á. Camacho, 2011, The Journal of antimicrobial chemotherapy.